Development Level

Tbio 9 | 11,445
Tchem 4 | 1,598
Tdark 1 | 6,588

IMPC Phenotype

abnormal skin condition 1 | 6
decreased circulating HDL chol... 1 | 68
decreased circulating choleste... 1 | 93
decreased mean corpuscular hem... 1 | 31
decreased mean corpuscular vol... 1 | 79

Disease

Carcinoma 13 | 11,493
osteosarcoma 10 | 7,950
psoriasis 7 | 6,694
Gingivitis 4 | 29
Mouth Infection Prevention 4 | 5
malignant mesothelioma 4 | 3,232
Anemia 3 | 365
Obesity 3 | 678
Rh Deficiency Syndrome 3 | 3
Systemic primary carnitine deficiency disease 3 | 15
Toxoplasmosis 3 | 17
lung cancer 3 | 4,740
lung carcinoma 3 | 2,843
mucosa-associated lymphoid tissue lymphoma 3 | 484
nasopharyngeal carcinoma 3 | 1,058
nephrosclerosis 3 | 333
non-small cell lung cancer 3 | 2,890
tuberculosis 3 | 2,010
Acquired metabolic disease 2 | 336
Anemia, Hemolytic, Congenital 2 | 3
Ataxic cerebral palsy 2 | 7
Atherosclerosis 2 | 291
Autoimmune hemolytic anemia 2 | 31
Autosomal recessive predisposition 2 | 1,442
Bilirubin metabolic disorder 2 | 41
Blood group incompatibility 2 | 4
Chromosome 3q29 microdeletion syndrome 2 | 11
Congenital hemolytic anemia 2 | 32
Coxsackievirus Infections 2 | 6
Kernicterus 2 | 11
Kidney Diseases 2 | 114
Metabolic acidosis 2 | 90
Myocarditis 2 | 18
Prostate cancer 2 | 175
Thrombocytopenia 2 | 197
cystic fibrosis 2 | 1,696
ependymoma 2 | 4,679
group 3 medulloblastoma 2 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
pancreatic cancer 2 | 2,398
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
pituitary cancer 2 | 1,972
spina bifida 2 | 1,074
Acute myeloid leukemia, disease 1 | 30
Anemia, Hemolytic 1 | 55
Appendiceal neoplasm 1 | 4
Autosomal recessive Robinow syndrome 1 | 27
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 1 | 13
Bipolar I disorder 1 | 23
Blastic phase chronic myeloid leukemia 1 | 58
Breast Neoplasms 1 | 445
Bronchioloalveolar Adenocarcinoma 1 | 14
Carcinoma of lung 1 | 3
Cardiac arrest 1 | 36
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic eosinophilic leukemia 1 | 11
Chronic phase chronic myeloid leukemia 1 | 45
Dermatofibrosarcoma protuberans 1 | 15
Familial cancer of breast 1 | 12
Gastrointestinal stromal tumor 1 | 62
Hepatitis C 1 | 94
Hereditary elliptocytosis 1 | 22
Histoplasmosis 1 | 13
Hypertrophic cardiomyopathy 20 1 | 12
Hyperuricemia 1 | 49
Idiopathic hypereosinophilic syndrome 1 | 10
Increased bilirubin level (finding) 1 | 18
Increased intracellular sodium 1 | 2
Increased red cell osmotic fragility 1 | 4
Inflammatory Bowel Diseases 1 | 35
Intracranial hypotension 1 | 10
Mammary Neoplasms 1 | 425
Metastatic Prostate Carcinoma 1 | 18
Myelodysplastic/ Myeloproliferative Diseases associated with Platelet-derived Growth Factor Receptor 1 | 9
Myocardial Infarction 1 | 151
Ovarian hyperstimulation syndrome 1 | 19
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Pneumocystosis jiroveci pneumonia 1 | 7
Pneumothorax 1 | 23
Poisoning 1 | 16
Prevention of Radiation-Induced Nausea and Vomiting 1 | 7
Relapsing remitting multiple sclerosis 1 | 14
Renal tubular acidosis 1 | 24
Reticulocytosis 1 | 20
Rhabdomyosarcoma 1 | 39
Rhabdomyosarcoma, Embryonal 1 | 5
Sarcoma 1 | 62
Skeletal muscle neoplasm 1 | 8
Stomatocytosis I 1 | 2
Stomatocytosis Result 1 | 6
Systemic mast cell disease 1 | 12
Thalassemia 1 | 53
Trachea leiomyoma 1 | 6
Tracheal stenosis 1 | 23
Unconjugated hyperbilirubinemia 1 | 4
Zollinger-Ellison syndrome 1 | 18
uncontrolled asthma 1 | 56

Tissue

Digestive Tract 14 | 17,369
Endocrine System 14 | 18,159
Male tissues 13 | 17,142
Skin and soft tissues 13 | 17,230
Urinary Tract 13 | 16,678
Blood and immune system 12 | 16,909
Female tissues 12 | 17,400
Liver and Pancreas 12 | 16,750
Cardiovascular System 10 | 15,192
Nervous System 10 | 16,725
Respiratory system 8 | 16,393

Target Family

Transporter 9 | 473
Non-IDG 5 | 12,091

GO Process

organic cation transport 14 | 14
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Solute carrier family 22 member 4 SLC22A4 Tbio Transporter -3.09928 1238.9 82
Solute carrier family 22 member 18 SLC22A18 Tbio Transporter -2.37972 229.8 107
Ammonium transporter Rh type A RHAG Tbio Non-IDG -3.03053 1073.1 38
Blood group Rh(D) polypeptide RHD Tbio Non-IDG -2.85217 685.8 120
Solute carrier family 22 member 3 SLC22A3 Tchem Transporter -2.08897 125.3 156
Solute carrier family 22 member 1 SLC22A1 Tchem Transporter -2.16768 152.4 206
Ammonium transporter Rh type B RHBG Tbio Non-IDG -1.63669 46.4 105
Blood group Rh(CE) polypeptide RHCE Tbio Non-IDG -3.02348 1046.8 80
Solute carrier family 22 member 14 SLC22A14 Tdark Transporter -0.37920 1.85 32
Solute carrier family 22 member 16 SLC22A16 Tbio Transporter -1.42855 25.4 105